Similar articles

• [Dangerous blood glucose peaks. Vascular damage even before diabetes].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Sep 4;145(35-36):53. MMW Fortschr Med. 2003. PMID: 14584214 German. No abstract available.
• [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2012 Feb 23;154(3):82-3. MMW Fortschr Med. 2012. PMID: 22458177 German. No abstract available.
• [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].

  Laakso M. Laakso M. Duodecim. 2003;119(20):1921-3. Duodecim. 2003. PMID: 14639996 Finnish. No abstract available.
• [Reducing postprandial glucose levels. Glucosidase antagonists].

  Neye H. Neye H. Pharm Unserer Zeit. 2002;31(3):272-8. doi: 10.1002/1615-1003(200205)31:3<272::AID-PAUZ272>3.0.CO;2-H. Pharm Unserer Zeit. 2002. PMID: 12071124 Review. German. No abstract available.
• Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.

  Zeymer U. Zeymer U. Int J Cardiol. 2006 Feb 8;107(1):11-20. doi: 10.1016/j.ijcard.2005.02.033. Int J Cardiol. 2006. PMID: 16337493 Review.